Overview Financials News + Filings Key Docs Charts Ownership Insiders |
|
ITEX CORP (ITEX)
|
Add to portfolio |
|
|
|
| Price: |
$4.42
| | Metrics |
| OS: |
2.06
|
M
| |
-21
|
% ROE
|
| Market cap: |
$9.08
|
M
| |
38
|
% ROIC
|
|
Net cash:
|
$3.83
|
M
| |
$1.86
|
per share
|
|
EV:
|
$5.26
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$1.2
|
M
| |
4.4
|
x EV/EBITDA
|
|
EBIT
|
$1.1
|
M
| |
4.7
|
x EV/EBIT
|
| EPS |
($0.85)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jul-31-16 | Jul-31-15 | Jul-31-14 | Jul-31-13 | Jul-31-12 | Jul-31-11 | Jul-31-10 | Jul-31-09 |
| Revenues | 11.1 | 12.0 | 13.5 | 14.8 | 15.8 | 16.4 | 4.3 | 4.1 |
| Revenue growth | -7.5% | -11.3% | -8.7% | -6.1% | -3.9% | 282.1% | 4.2% | 3.3% |
| Cost of goods sold | 8.7 | 9.3 | 10.5 | 11.4 | 12.1 | 12.2 | 0.0 | 0.0 |
| Gross profit | 2.4 | 2.8 | 3.0 | 3.4 | 3.6 | 4.3 | 4.3 | 4.1 |
| Gross margin | 22.0% | 23.0% | 22.1% | 22.9% | 23.1% | 26.0% | 100.0% | 100.0% |
| Selling, general and administrative | 1.1 | 1.7 | 2.0 | 1.7 | 2.2 | 2.6 | 2.0 | 2.3 |
| EBITA | 1.3 | 1.0 | 0.9 | 1.7 | 1.7 | 1.2 | 1.7 | 1.0 |
| EBITA margin | 11.5% | 8.4% | 6.9% | 11.5% | 10.6% | 7.3% | 38.9% | 24.9% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | | | |
| EBIT | 1.2 | 1.0 | 0.8 | 1.5 | 1.4 | 1.2 | 1.7 | 1.0 |
| EBIT margin | 11.1% | 8.0% | 6.3% | 9.9% | 9.0% | 7.3% | 38.9% | 24.9% |
| Pre-tax income | -0.5 | 1.0 | 1.0 | 1.6 | 1.5 | 1.3 | 1.6 | 1.0 |
| Income taxes | 1.1 | 0.4 | 0.3 | 0.5 | 0.6 | 0.6 | 0.6 | 0.4 |
| Tax rate | | 34.1% | 31.0% | 31.9% | 36.4% | 44.0% | 39.2% | 41.0% |
| Net income | -1.5 | 0.7 | 0.7 | 1.1 | 1.0 | 0.7 | 0.9 | 0.6 |
| Net margin | -13.7% | 5.7% | 4.9% | 7.2% | 6.1% | 4.3% | 22.0% | 14.7% |
| |
| Diluted EPS | ($0.79) | $0.00 | $0.25 | $0.41 | $0.29 | $0.19 | $0.26 | $0.17 |
| Shares outstanding (diluted) | 1.9 | 2,423.0 | 2.7 | 2.6 | 3.3 | 3.6 | 3.6 | 3.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|